The test will be used to detect metastatic and recurring cancers at an earlier stage, and could also be used for the long term to monitor how well patients respond to chemotherapy or other treatment, the researchers predicted. “The blood test developed by our team of researchers offers a new and revolutionary opportunity to detect cancer in the breast quickly and noninvasively using biomarkers in the blood,” said study author, MD, PhD, managing medical director, University Women’s Hospital, Heidelberg University Hospital, Heidelberg, Germany.
The test isn’t meant to entirely replace standard types of screening such as mammograms, ultrasounds, and MRI scans, but to be used to complement them. “The new blood-based procedure is much less of a burden on women, since it isn’t painful and doesn’t involve exposure to radiation,” said Sarah Schott, MD, PhD, section head, Translational…
